Modern pharmaceutical development can be simplified into three linked tasks. First is identifying the genetic mutations and pathways that drive disease. Second is translating those insights into a therapeutic molecule—the pill or infusion a patient eventually receives. Third is proving safety and efficacy through clinical trials, which consume the majority of time and capital. Moving from target to approved medicine often takes close to a decade.